Determining siRNA selection
What is important when selecting an siRNA library? Design and
performance are just a starting point for the use of this technology.
Large-scale siRNA
screens can generate
hundreds of potential
‘hits’ – genes for which
one or more siRNAs give
a desired phenotype.
Unfortunately, in early
screens with unmodified
siRNA technologies and
pooled siRNA approaches,
many of these hits are
actually because of offtarget
effects.
‘The first concern is the
quality of the algorithm
that is used to design
the siRNAs,’ says Anand
Ganesan MD, PhD, assistant
professor, Department of
Dermatology and Biological
Chemistry at the University
of California, Irvine.
‘Secondly, the number of
siRNAs that have been
validated either by the
company or as a part of
other studies should be
considered.’
Ambion® Silencer® Select
siRNAs incorporate the latest
improvements in siRNA
design, off-target effect
prediction algorithms and
chemistry. As a result, they
provide unrivalled silencing
consistency, potency and
specificity, and fewer failed
experiments, resulting in
cleaner, more consistent
phenotypic data.
siRNA quality
siRNA design and structure
are important; however,
siRNA manufacturing
quality is equally critical.
Ambion® Silencer® Select
siRNAs are manufactured
under highly controlled
processes, and are subjected
to rigorous quality control
procedures.
Dr Hakim Djaballah,
director of the High
Throughput Screening Core
Facility at Memorial Sloan
Kettering Cancer Center,
says: ‘Cellular viability is
a major concern in our
screening experiments.
We need to know that the
contaminants that result
from the production of
siRNA are at extremely low
levels. Often we dilute our
reagents, and use them on
a small scale with a small
number of cells and we
cannot afford for impurities
to be present.’
Customisation concerns
siRNA screens are quite
varied in nature. ‘Every
experiment has different
requirements,’ says
Djaballah. ‘What is the scale
of siRNA desired in each
well? How are the duplexes
oriented? Can the supplier
provide custom aliquotting?
Most importantly, what are
the turnaround times for
ordered libraries?’ All are
critical factors in selecting a
siRNA library vendor, both
for the initial siRNA library
purchase, as well as for hit
confirmation follow-up
studies.
Ambion Silencer Select
siRNA libraries are available
at scales of 0.1, 0.25, 1.0,
2.0 and 5.0 nmol per well.
Custom aliquotting requests
of all types are easily
handled, and the company
can supply siRNAs in your
desired plate layouts to
match your transfection and
cell-based assay protocols.
Validation
Once hits from a library
screen are identified,
validation is a crucial
step prior to drawing
conclusions. ‘We don’t
think simply using
another supplier’s siRNA
is a good enough method
for validation if you are
relying on the differences
between the two suppliers’
algorithms,’ says Djaballah.
‘We prefer qRT-PCR
followed by protein
level measurements. We
sometimes look at rescue
experiments using an
expression vector, but these
can be tedious and there can
be toxicity concerns.’
‘We validate hits by several
different strategies,’
Ganesan explains. ‘We
use multiple siRNAs to
eliminate off targets. We
carry out quantitative
qRT-PCR to ensure that
the siRNA impacts the
expression of the target
gene, and we examine the
impact of these siRNAs in
several different cell lines.
More recently, we have also
been validating our hits
with shRNAs. The major
cost of screens is usually not
from the screen itself, but
from the follow ups.’
Ambion, now within the
Invitrogen family, can help
clients define an appropriate
follow-up and hit validation
strategy. Since 2002, the
company has consulted with
and helped thousands of
scientists using siRNAs.
|
 |
Company profile
Life Technologies is a global
biotechnology tools company
dedicated to improving the
human conditon. Its systems, consumables and services
enable researchers to accelerate
scientific exploration, driving to
discoveries and developments
that improve life.
For further information, visit:
www.appliedbiosystems.com/
select.

|